ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Remission in CRSwNP"
Episode Synopsis
Professor Peter Hellings and Dr. Stella Lee discuss the concept of remission for patients with chronic rhinosinusitis with nasal polyps.
ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.
This podcast is intended for healthcare professionals only.
Disclaimer:
This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program.
The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits.
Speaker disclosures:
Professor Peter Hellings has received clinical trial funding and/or advisory board fees from Sanofi, Novartis, GlaxoSmithKline, Stallergenes, ALK, Viatris/Mylan.
Doctor Stella Lee has received clinical trial funding and/or advisory board fees from AstraZeneca, Genentech, GlaxoSmithKline, Lyra Therapeutics, OptiNose, Sanofi and Regeneron.
© 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-GLB-2400409 v1.0 03/2024
MAT-US-2402818 v1.0 - P Expiration Date: 03/12/2026
ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.
This podcast is intended for healthcare professionals only.
Disclaimer:
This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program.
The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits.
Speaker disclosures:
Professor Peter Hellings has received clinical trial funding and/or advisory board fees from Sanofi, Novartis, GlaxoSmithKline, Stallergenes, ALK, Viatris/Mylan.
Doctor Stella Lee has received clinical trial funding and/or advisory board fees from AstraZeneca, Genentech, GlaxoSmithKline, Lyra Therapeutics, OptiNose, Sanofi and Regeneron.
© 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-GLB-2400409 v1.0 03/2024
MAT-US-2402818 v1.0 - P Expiration Date: 03/12/2026
In God we trust